FORMA Therapeutics Teams With TGen Drug Development
FORMA Therapeutics and TGen Drug Development (TD2) announced an agreement to jointly develop transformative cancer therapies, leveraging the synergistic capabilities of both organizations. “TD2 brings preclinical and clinical development capabilities…